Subcutaneous Emphysema

Explore clinical trials studying Subcutaneous Emphysema. Study availability and eligibility vary by location and protocol.

5 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Subcutaneous Emphysema trial results

Recruiting

NCT07431112

Conditions: Alpha 1 Antitrypsin Deficiency, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations: Clinical Study Center Melbourne, Australia

Clinical Study Center 1 Tbilisi, Georgia

Clinical Study Center 2 Tbilisi, Georgia

Clinical Study Center Cambridge, United Kingdom

Recruiting

NCT07555483

Conditions: Alpha 1 Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations: GC2501 Study Site 106 Birmingham, Alabama, United States

GC2501 Study Site 102 Phoenix, Arizona, United States

GC2501 Study Site 107 Scottsdale, Arizona, United States

GC2501 Study Site 100 Los Angelas, California, United States

View all 22 locations

Completed

NCT05963945

Completed

NCT04722887

Conditions: Alpha1-Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations: UCLA Medical Center Los Angeles, California, United States

University of Florida Gainesville, Florida, United States

University of Miami Miami, Florida, United States

Cleveland Clinic Cleveland, Ohio, United States

Completed

NCT04840953

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +14 more
Locations: Hospital General Universitario de Elche Elche, Alicante, Spain